Metropolitan Life Insurance Company (MetLife)’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-4,118
| Closed | -$21.2K | – | 2685 |
|
|
2019
Q2 | $21.2K | Buy |
+4,118
| New | +$21.2K | ﹤0.01% | 2600 |
|
|
2019
Q1 | – | Sell |
-17,040
| Closed | -$104K | – | 2589 |
|
|
2018
Q4 | $104K | Hold |
17,040
| – | – | ﹤0.01% | 2240 |
|
|
2018
Q3 | $99.5K | Buy |
+17,040
| New | +$99.5K | ﹤0.01% | 2456 |
|
|
2018
Q1 | – | Sell |
-1,415
| Closed | -$7K | – | 2518 |
|
|
2017
Q4 | $7K | Sell |
1,415
-28,944
| -95% | -$143K | ﹤0.01% | 2500 |
|
|
2017
Q3 | $186K | Sell |
30,359
-90
| -0.3% | -$551 | ﹤0.01% | 2313 |
|
|
2017
Q2 | $220K | Buy |
30,449
+4,830
| +19% | +$34.9K | ﹤0.01% | 2282 |
|
|
2017
Q1 | $136K | Buy |
25,619
+3,883
| +18% | +$20.6K | ﹤0.01% | 2409 |
|
|
2016
Q4 | $156K | Sell |
21,736
-1,002
| -4% | -$7.19K | ﹤0.01% | 2482 |
|
|
2016
Q3 | $213K | Sell |
22,738
-2,971
| -12% | -$27.8K | ﹤0.01% | 2299 |
|
|
2016
Q2 | $162K | Buy |
+25,709
| New | +$162K | ﹤0.01% | 2470 |
|
|
2015
Q4 | – | Sell |
-20,686
| Closed | -$175K | – | 2664 |
|
|
2015
Q3 | $175K | Buy |
20,686
+518
| +3% | +$4.38K | ﹤0.01% | 2374 |
|
|
2015
Q2 | $305K | Buy |
20,168
+358
| +2% | +$5.41K | ﹤0.01% | 2107 |
|
|
2015
Q1 | $317K | Sell |
19,810
-2,328
| -11% | -$37.3K | ﹤0.01% | 1811 |
|
|
2014
Q4 | $394K | Buy |
22,138
+2,514
| +13% | +$44.7K | ﹤0.01% | 1931 |
|
|
2014
Q3 | $197K | Hold |
19,624
| – | – | ﹤0.01% | 2373 |
|
|
2014
Q2 | $306K | Buy |
+19,624
| New | +$306K | ﹤0.01% | 2190 |
|